My WebLink
|
Help
|
About
|
Sign Out
Home
RES 162 Draft 01 2010-2012
ClerkCouncil
>
Council Records
>
Resolutions
>
2010-2012
>
RES 162 Draft 01 2010-2012
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
10/28/2011 2:02:58 PM
Creation date
9/26/2011 2:24:56 PM
Metadata
Fields
Template:
Bill/Resolution
Bill/Resolution - Type
RES
Bill/Resolution - Council Term
2010-2012
Bill/Resolution
162
Draft
01
Introducer
Brenda J. Ford, Council Member
Referred To
FC
Action 1
Council: Adopts Res. 162-11 & FC-127 - 10/19/11
Status
Adopted
Date To Mayor or Adoption Date
10/19/2011
Reading Number
1
Reading Date
10/19/2011
Ayes
7-Blas;Ford;Hoffmann;Onishi,Pilago;Smart;Yoshimoto
Noes
0
Absent
2-Ikeda;Yagong
Excused
0
Document Relationships
AGE COUNCIL 10/19/2011 2010-2012
(Related To)
Path:
\Council Records\Agendas\2010-2012\Council
AGE FC 10/04/2011 2010-2012
(Related)
Path:
\Council Records\Agendas\2010-2012\Finance Committee (FC)
BIL 108 Draft 01 2010-2012
(Related To)
Path:
\Council Records\Bills\2010-2012
BIL 108 Draft 01 2010-2012
(Related)
Path:
\Council Records\Bills\2010-2012
COM 0378.000 2010-2012
(Related)
Path:
\Council Records\Communications\2010-2012
COM 0378.000 2010-2012
(Related To)
Path:
\Council Records\Communications\2010-2012
REP FC 127 10/04/2011 2010-2012
(Related To)
Path:
\Council Records\Reports\2010-2012\Finance Committee (FC)
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
7
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
Addendum A <br />STATE AND LOCAL HIDTA TASK FORCE AGREEMENT <br />BETWEEN <br />THE DRUG ENFORCEMENT ADMINISTRATION <br />AND <br />OFFICE OF THE PROSECUTING ATTORNEY HAWAII COUNTY <br />To accomplish the objectives of the Drug Enforcement Administration (DEA) High Intensity <br />Drug Trafficking Area (HIDTA) Pharmaceutical Initiative, the Office of the Prosecuting <br />Attorney, Hawaii County (OPA) agrees to assign one (1) experienced investigator to the <br />Pharmaceutical Initiative. <br />Under the DEA Table of Organization for the DEA Honolulu District Office (HDO), the <br />available HIDTA Task Force Officer (TFO) position is assigned to the DEA Hawaii Airport <br />Task Force (HATF). In order to accomplish the mission of the Pharmaceutical Initiative, the <br />DEA HDO agrees to temporarily duty (TDY) assign this TFO position from the HATF to the <br />Pharmaceutical Initiative. <br />It is understood that the investigator that OPA will assign to the DEA Task Force will continue <br />to perform their core duties and obligations to OPA. However, when HIDTA Pharmaceutical <br />Investigations arise, the investigator that OPA will assign to the DEA Task Force will perform <br />the activities and duties described below: <br />a. Investigate, disrupt and dismantle individuals and/or organizations involved in <br />diversion schemes (e.g., "doctor shopping ", prescription forgery, and prevalent retail - <br />level violators) of controlled pharmaceuticals and /or listed chemicals in the Big <br />Island area; <br />b. Investigate, gather and report intelligence data relating to trafficking of controlled <br />pharmaceuticals and /or listed chemicals; and <br />c. Conduct undercover operations where appropriate and engage in other traditional <br />methods of investigation in order that the Task Force's activities will result in <br />effective prosecution before the courts of the United States and the State of Hawaii. <br />It is further understood that once signed by all listed parties, the OPA and DEA are bound by <br />the Hawaii Airport Task Force State and Local HIDTA Task Force Agreement between The <br />Drug Enforcement Administration and the Office of the Prosecuting Attorney for Hawaii <br />County. It is further understood as outlined in the agreement in paragraph six that during the <br />period of assignment to the HATF, the OPA will remain responsible for establishing the <br />salary and benefits, including, overtime, of the OPA officer assigned to the <br />HATF/Pharmaceutical Initiative and for making all payments due to them. HIDTA will, <br />subject to availability of funds, reimburse the OPA for overtime payments made by it to the <br />
The URL can be used to link to this page
Your browser does not support the video tag.